Pharmacotherapy of Status Epileptics
Pharmacotherapy of Status Epileptics
Pharmacotherapy of Status Epileptics
PHARMACOTHERAPY
OF STATUS EPILEPTICS
➢ Identify etiology of SE
anticonvulsant withdrawal
metabolic disorder
concurrent illness
progression of a preexisting neurologic disease.
Alcohol withdrawals
Low level of AED in the plasma
Trauma
CNS tumor
Etiology
7
Pathophysiology
10
phase II immediately
the EEG ictal discharge and clonic motor activity
become continuous, and the patient begins to decompensate
The patient become hypotensive
Auto-regulation of cerebral blood flow becomes dependent on
mean arterial pressure and begins to fail.
There continues to be an excessive consumption of oxygen and
glucose
however, compensatory mechanisms are no longer
able to meet demands.
Hyperthermia and respiratory deterioration with hypoxia and
ventilatory failure, metabolic acidosis, hyperkalemia,
hyponatremia, and azotemia, may develop
Mortality and morbidity
11
Observation
physical examination
The nature and duration of the seizure but a diagnosis
of GCSE should not be made until a clinician has
observed a seizure.
Laboratory tests are essential
RFT, LFT, electrolyte
Diagnostic test
MRI, EEG, CT, Radiograph
16
Treatment
What is expected from the treatment?
immediate termination of all clinical and electrical
seizure activity
no clinically significant adverse effects
pharmacoresistant epilepsy
the development of neurologic sequelae that significantly
impact quality of life
Treatment
17
Non pharmacologic
Vital signs should be assessed
Pharmacologic
When a seizure does not stop within 5 minutes, or
Benzodiazepines
benzodiazepines are effective initial therapy in most
patients and should be administered as soon as
possible.
Generally, one or two IV doses will terminate seizures
within 2 to 3 minutes.
which BZD?
Phenytoin
A hydantoin is the second-line agent in GCSE that is
◼ unresponsive to the benzodiazepines or
◼ seizures that recur after successful treatment with a
benzodiazepine
it is effective in terminating seizures in 40% to 91%
of patients
it can be inferior to lorazepam, phenobarbital, or
diazepam plus phenytoin at stopping GCSE within
20 minutes of their infusion
Treatment
22
Fosphenytoin
Fosphenytoin, a water-soluble phosphate ester, has no
Phenobarbital
Phenobarbital has biphasic distribution into body
organs.
During phase I, the drug distributes into highly vascular
organs, but does not distribute into the brain.
With the exception of fat, phenobarbital distributes
throughout the body during phase II
Although the highest brain concentrations occur 12 to 60
minutes after an IV dose, seizures are controlled within
minutes of the loading dose.
phenobarbital be given after a benzodiazepine plus
phenytoin has failed.
Treatment
27
How do we treat
special population?
Refractory GCSE?
Treatment
29
Treatment
30
Evaluation of therapeutic outcome
31
Success
Initial
Ultimate